Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss	Accumulated Deficit [Member]
Balance at Dec. 31, 2020	$ 134,664	$ 2	$ 264,487		$ (129,825)
Balance (in shares) at Dec. 31, 2020		22,599,048
Proceeds from issuance of common stock, net of issuance costs	52,983		52,983
Stock issued during the period (shares)		3,000,000
Stock-based compensation expense	1,172		1,172
Vesting of restricted common stock		5,171
Exercise of stock options to purchase common stock	98		98
Exercise of stock options to purchase common stock (shares)		22,470
Net loss	(12,663)				(12,663)
Balance at Mar. 31, 2021	176,255	$ 3	318,740		(142,488)
Balance (in shares) at Mar. 31, 2021		25,626,689
Balance at Dec. 31, 2020	134,664	$ 2	264,487		(129,825)
Balance (in shares) at Dec. 31, 2020		22,599,048
Proceeds from issuance of common stock, net of issuance costs	52,983
Net loss	(28,191)
Balance at Jun. 30, 2021	162,632	$ 3	320,645		(158,016)
Balance (in shares) at Jun. 30, 2021		25,741,072,000
Balance at Mar. 31, 2021	176,255	$ 3	318,740		(142,488)
Balance (in shares) at Mar. 31, 2021		25,626,689
Stock-based compensation expense	1,656		1,656
Vesting of restricted common stock		5,170,000
Exercise of stock options to purchase common stock	249		249
Exercise of stock options to purchase common stock (shares)		109,213,000
Net loss	(15,528)				(15,528)
Balance at Jun. 30, 2021	162,632	$ 3	320,645		(158,016)
Balance (in shares) at Jun. 30, 2021		25,741,072,000
Balance at Dec. 31, 2021	130,022	$ 3	324,620	$ (14)	(194,587)
Balance (in shares) at Dec. 31, 2021		25,848,229
Stock-based compensation expense	1,980		1,980
Exercise of stock options to purchase common stock	62		62
Exercise of stock options to purchase common stock (shares)		34,967
Other comprehensive loss	(26)			(26)
Net loss	(17,780)				(17,780)
Balance at Mar. 31, 2022	114,258	$ 3	326,662	(40)	(212,367)
Balance (in shares) at Mar. 31, 2022		25,883,196
Balance at Dec. 31, 2021	130,022	$ 3	324,620	(14)	(194,587)
Balance (in shares) at Dec. 31, 2021		25,848,229
Proceeds from issuance of common stock, net of issuance costs	$ 0
Exercise of stock options to purchase common stock (shares)	34,863,000
Issuance of common stock under employee stock purchase plans, Shares		89,112
Net loss	$ (36,871)
Balance at Jun. 30, 2022	98,008	$ 3	329,504	(41)	(231,458)
Balance (in shares) at Jun. 30, 2022		25,972,411,000
Balance at Mar. 31, 2022	114,258	$ 3	326,662	(40)	(212,367)
Balance (in shares) at Mar. 31, 2022		25,883,196
Stock-based compensation expense	2,180		2,180
Exercise of stock options to purchase common stock (shares)		103,000
Issuance of common stock under employee stock purchase plans, Shares		89,112,000
Issuance of common stock under employee stock purchase plans	95		95
Issuance of warrants in connection with term loan financing	567		567
Other comprehensive loss	(1)			(1)
Net loss	(19,091)				(19,091)
Balance at Jun. 30, 2022	$ 98,008	$ 3	$ 329,504	$ (41)	$ (231,458)
Balance (in shares) at Jun. 30, 2022		25,972,411,000